同大類學(xué)科其它級(jí)別期刊:
中科院 1區(qū) 期刊 JCR Q1 期刊 中科院 2區(qū) 期刊 JCR Q2 期刊 中科院 3區(qū) 期刊 JCR Q3 期刊 中科院 4區(qū) 期刊 JCR Q4 期刊國(guó)際簡(jiǎn)稱:INFECT AGENTS CANCER 參考譯名:傳染性病原體和癌癥
主要研究方向:ONCOLOGY-IMMUNOLOGY 非預(yù)警期刊 審稿周期: 17 Weeks
《傳染性病原體和癌癥》(Infectious Agents And Cancer)是一本由BioMed Central出版的以O(shè)NCOLOGY-IMMUNOLOGY為研究特色的國(guó)際期刊,發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章,及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn),旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本開放期刊,近三年沒有被列入預(yù)警名單。該期刊享有很高的科學(xué)聲譽(yù),影響因子不斷增加,發(fā)行量也同樣高。
Infectious Agents and Cancer is an open access, peer-reviewed online journal that encompasses all aspects of basic, clinical, epidemiological and translational research providing an insight into the association between chronic infections and cancer.
The journal welcomes submissions in the pathogen-related cancer areas and other related topics, in particular:
? HPV and anogenital cancers, as well as head and neck cancers;
? EBV and Burkitt lymphoma;
? HCV/HBV and hepatocellular carcinoma as well as lymphoproliferative diseases;
? HHV8 and Kaposi sarcoma;
? HTLV and leukemia;
? Cancers in Low- and Middle-income countries.
The link between infection and cancer has become well established over the past 50 years, and infection-associated cancer contribute up to 16% of cancers in developed countries and 33% in less developed countries.
Preventive vaccines have been developed for only two cancer-causing viruses, highlighting both the opportunity to prevent infection-associated cancers by vaccination and the gaps that remain before vaccines can be developed for other cancer-causing agents. These gaps are due to incomplete understanding of the basic biology, natural history, epidemiology of many of the pathogens that cause cancer, the mechanisms they exploit to cause cancer, and how to interrupt progression to cancer in human populations. Early diagnosis or identification of lesions at high risk of progression represent the current most critical research area of the field supported by recent advances in genomics and proteomics technologies.
CiteScore | SJR | SNIP | CiteScore 指數(shù) | ||||||||||||||||||||
5.8 | 0.424 | 0.81 |
|
名詞解釋:CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù),是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年(含計(jì)算年度)的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如,2022年的 CiteScore 計(jì)算方法為:2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量 注:文獻(xiàn)類型包括:文章、評(píng)論、會(huì)議論文、書籍章節(jié)和數(shù)據(jù)論文。
Top期刊 | 綜述期刊 | 大類學(xué)科 | 小類學(xué)科 | ||
否 | 否 | 醫(yī)學(xué) | 2區(qū) | IMMUNOLOGY 免疫學(xué) ONCOLOGY 腫瘤學(xué) | 3區(qū) 3區(qū) |
Top期刊 | 綜述期刊 | 大類學(xué)科 | 小類學(xué)科 | ||
否 | 否 | 醫(yī)學(xué) | 3區(qū) | IMMUNOLOGY 免疫學(xué) ONCOLOGY 腫瘤學(xué) | 3區(qū) 3區(qū) |
Top期刊 | 綜述期刊 | 大類學(xué)科 | 小類學(xué)科 | ||
否 | 否 | 醫(yī)學(xué) | 4區(qū) | IMMUNOLOGY 免疫學(xué) ONCOLOGY 腫瘤學(xué) | 4區(qū) 4區(qū) |
Top期刊 | 綜述期刊 | 大類學(xué)科 | 小類學(xué)科 | ||
否 | 否 | 醫(yī)學(xué) | 3區(qū) | IMMUNOLOGY 免疫學(xué) ONCOLOGY 腫瘤學(xué) | 4區(qū) 4區(qū) |
Top期刊 | 綜述期刊 | 大類學(xué)科 | 小類學(xué)科 | ||
否 | 否 | 醫(yī)學(xué) | 4區(qū) | IMMUNOLOGY 免疫學(xué) ONCOLOGY 腫瘤學(xué) | 4區(qū) 4區(qū) |
Top期刊 | 綜述期刊 | 大類學(xué)科 | 小類學(xué)科 | ||
否 | 否 | 醫(yī)學(xué) | 3區(qū) | IMMUNOLOGY 免疫學(xué) ONCOLOGY 腫瘤學(xué) | 3區(qū) 3區(qū) |
按JIF指標(biāo)學(xué)科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學(xué)科:IMMUNOLOGY | SCIE | Q3 | 102 / 181 |
43.9% |
學(xué)科:ONCOLOGY | SCIE | Q2 | 136 / 322 |
57.9% |
按JCI指標(biāo)學(xué)科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學(xué)科:IMMUNOLOGY | SCIE | Q3 | 97 / 181 |
46.69% |
學(xué)科:ONCOLOGY | SCIE | Q3 | 172 / 322 |
46.74% |
Author: Zeng, Jindi; Wu, Jiancheng; Pang, Shuijiao; Wang, Feifei; Yu, Xin; Zhang, Shouhua; Zeng, Junquan; Yan, Jinlong; Lian, Jianping
Journal: INFECTIOUS AGENTS AND CANCER. 2023; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13027-023-00502-1
Author: Liu, Min; Lu, Jianqiao; Zhi, Yong; Ruan, Yetian; Cao, Guangxu; Xu, Xinxin; An, Xin; Gao, Jinli; Li, Fang
Journal: INFECTIOUS AGENTS AND CANCER. 2023; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13027-023-00498-8
Author: Yang, Jianming; Chen, Yewu; Sun, Haobin; Zhang, Xijian; Wang, Jianfeng; Liang, Zhixing; Fu, Binsheng; Zhang, Tong; Yi, Shuhong; Deng, Yinan; Yang, Yang
Journal: INFECTIOUS AGENTS AND CANCER. 2023; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13027-022-00478-4
Author: Wan, B.; Wei, L. J.; Tan, T. M.; Qin, L.; Wang, H.
Journal: INFECTIOUS AGENTS AND CANCER. 2023; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13027-023-00483-1
Author: Yang, Chen; Yang, Xiaofeng; Liu, Chenghao; Hou, Jun; Chen, Xueling; Wang, Lianghai; Wu, Xiangwei
Journal: INFECTIOUS AGENTS AND CANCER. 2023; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13027-023-00503-0
Author: Li, Guanghua; Zhou, Zhihao; Wang, Zhixiong; Wang, Zhao
Journal: INFECTIOUS AGENTS AND CANCER. 2023; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13027-023-00489-9
Author: Zhang, Zhenchao; Li, Dongxian; Li, Yuhua; Zhang, Rui; Xie, Xianghuan; Yao, Yi; Zhao, Linfei; Tian, Xiaowei; Yang, Zhenke; Wang, Shuai; Yue, Xuejing; Mei, Xuefang
Journal: INFECTIOUS AGENTS AND CANCER. 2023; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13027-023-00490-2
Author: Moussavou-Boundzanga, Pamela; Koumakpayi, Ismael Herve; Engohan Aloghe, Corinne; Chansi, Junie K.; Revignet, Rose; Leroy, Eric M.; Berthet, Nicolas
Journal: INFECTIOUS AGENTS AND CANCER. 2023; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13027-023-00493-z
Frontiers In Public Health
中科院 3區(qū) JCR Q2
Frontiers In Pharmacology
中科院 2區(qū) JCR Q1
Biomedicine & Pharmacotherapy
中科院 2區(qū) JCR Q1
Discover Oncology
中科院 4區(qū) JCR Q2
Bmc Psychiatry
中科院 2區(qū) JCR Q2
Bmc Neurology
中科院 3區(qū) JCR Q3
Journal Of Materials Chemistry B
中科院 3區(qū) JCR Q1
Medcomm
中科院 3區(qū) JCR Q1
若用戶需要出版服務(wù),請(qǐng)聯(lián)系出版商:CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW。